BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

729 related articles for article (PubMed ID: 8897120)

  • 1. The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer.
    Huang JC; Jackson KV; Hornstein MD; Ginsburg ES
    J Assist Reprod Genet; 1996 Sep; 13(8):617-24. PubMed ID: 8897120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The appearance of one-pronuclear human oocytes is associated with a better ovulation-induction response and successful pregnancy outcome.
    Jackson KV; Nureddin A; Clarke RN; Hornstein MD; Rein MS; Friedman AJ
    Fertil Steril; 1992 Aug; 58(2):366-72. PubMed ID: 1633904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live birth rates after IVF are reduced by both low and high progesterone levels on the day of human chorionic gonadotrophin administration.
    Santos-Ribeiro S; Polyzos NP; Haentjens P; Smitz J; Camus M; Tournaye H; Blockeel C
    Hum Reprod; 2014 Aug; 29(8):1698-705. PubMed ID: 24939956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles.
    Givens CR; Schriock ED; Dandekar PV; Martin MC
    Fertil Steril; 1994 Nov; 62(5):1011-7. PubMed ID: 7926111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should progesterone on the human chorionic gonadotropin day still be measured?
    Martinez F; Rodriguez I; Devesa M; Buxaderas R; Gómez MJ; Coroleu B
    Fertil Steril; 2016 Jan; 105(1):86-92. PubMed ID: 26453983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
    Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
    Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual trigger with gonadotropin-releasing hormone agonist and recombinant human chorionic gonadotropin improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles.
    Seval MM; Özmen B; Atabekoğlu C; Şükür YE; Şimşir C; Kan Ö; Sönmezer M
    J Obstet Gynaecol Res; 2016 Sep; 42(9):1146-51. PubMed ID: 27199084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship among serum levels of luteinizing hormone, estradiol, and progesterone during follicle stimulation and results of in vitro fertilization and embryo transfer (IVF-ET).
    Kagawa T; Yamano S; Nishida S; Murayama S; Aono T
    J Assist Reprod Genet; 1992 Apr; 9(2):106-12. PubMed ID: 1627924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
    Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
    Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles.
    Wu Z; Li R; Ma Y; Deng B; Zhang X; Meng Y; Chen X; Liu P; Qiao J
    Reprod Biomed Online; 2012 May; 24(5):511-20. PubMed ID: 22417667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
    Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
    Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteinizing response to human chorionic gonadotropin does not predict outcome in gonadotropin releasing hormone agonist-suppressed/human menopausal gonadotropin-stimulated in vitro fertilization (IVF) cycles.
    Penzias AS; Shamma FN; Gutmann JN; Seifer DB; DeCherney AH; Lavy G
    J Assist Reprod Genet; 1992 Jun; 9(3):244-7. PubMed ID: 1525454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.
    Andersen CY; Elbaek HO; Alsbjerg B; Laursen RJ; Povlsen BB; Thomsen L; Humaidan P
    Hum Reprod; 2015 Oct; 30(10):2387-95. PubMed ID: 26209535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated with diminished ovarian reserve.
    Hofmann GE; Khoury J; Michener C
    Fertil Steril; 2002 Jul; 78(1):47-50. PubMed ID: 12095489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles.
    Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
    Hum Reprod; 2015 Mar; 30(3):684-91. PubMed ID: 25586787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer.
    Fanchin R; de Ziegler D; Taieb J; Hazout A; Frydman R
    Fertil Steril; 1993 May; 59(5):1090-4. PubMed ID: 8486179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The initial flare-up induced by gonadotropin releasing hormone agonist may serve as a predictor of ovarian response in the current IVF-ET treatment cycle in normogonadotropic women aged 40-48 years.
    Avrech OM; Royburt M; Sabah G; Zukerman Z; Pinkas H; Amit S; Ovadia J; Fisch B
    J Assist Reprod Genet; 1996 May; 13(5):395-400. PubMed ID: 8739055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the effect of premature elevated progesterone augmented by human chorionic gonadotropin versus gonadotropin-releasing hormone agonist trigger?
    Connell MT; Patounakis G; Healy MW; DeCherney AH; Devine K; Widra E; Levy MJ; Hill MJ
    Fertil Steril; 2016 Sep; 106(3):584-589.e1. PubMed ID: 27178228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproducibility and clinical significance of pre-ovulatory serum progesterone level and progesterone/estradiol ratio on the day of human chorionic gonadotropin administration in infertile women undergoing repeated in vitro fertilization cycles.
    Lin YJ; Lan KC; Huang FJ; Lin PY; Chiang HJ; Kung FT
    Reprod Biol Endocrinol; 2015 May; 13():41. PubMed ID: 25967104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.